Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Am J Med ; 77(5B): 116-22, 1984 Nov 19.
Artículo en Inglés | MEDLINE | ID: mdl-6095655

RESUMEN

This study was undertaken to assess the clinical usefulness of a single nighttime dose of ranitidine in the short-term healing of duodenal ulcer. One hundred and nine patients with endoscopically diagnosed duodenal ulcer were randomly allocated to treatment with ranitidine, either 150 mg twice daily or 300 mg as a single nighttime dose for four weeks, in a prospective double-blind, double-placebo trial. Of the 102 patients who completed the study, 48 of 57 (84 percent) healed endoscopically on ranitidine 150 mg twice daily, and 43 of 45 (96 percent) healed on 300 mg at nighttime (Mantel-Haenszel test without continuity correction: X2 = 2.9, p = 0.09). One patient treated with ranitidine 150 mg twice daily had a transient episode of cholestatic hepatitis that did not necessitate stopping the drug; in this patient the ulcer healed after 28 days of treatment. There were no other unwanted effects in either group and no significant abnormal biochemical or hematologic changes. This study shows that ranitidine 300 mg given as one nighttime dose is as safe as 150 mg twice daily, and equally as effective. Three hundred milligrams at night appear to confer protection against the adverse effect of smoking in ulcer healing.


Asunto(s)
Ritmo Circadiano/efectos de los fármacos , Úlcera Duodenal/fisiopatología , Ácido Gástrico/metabolismo , Ranitidina/administración & dosificación , Adolescente , Adulto , Anciano , Antiácidos/uso terapéutico , Ensayos Clínicos como Asunto , Método Doble Ciego , Úlcera Duodenal/tratamiento farmacológico , Femenino , Humanos , Concentración de Iones de Hidrógeno , Masculino , Persona de Mediana Edad , Placebos , Ranitidina/efectos adversos , Fumar , Factores de Tiempo
2.
Arch Pathol Lab Med ; 110(3): 250-1, 1986 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-3753863

RESUMEN

We report a case of advanced, unruptured tubal pregnancy proceeding beyond term. A 25-year-old woman was admitted at 42 weeks' gestation because of lower abdominal pain and inability to feel fetal movements. An ultrasound examination suggested fetal death. At laparotomy three weeks after admission, a right-sided, unruptured tubal mass containing a macerated fetus was found.


Asunto(s)
Embarazo Tubario/patología , Adulto , Trompas Uterinas/patología , Femenino , Humanos , Embarazo
3.
Lancet ; 2(8397): 274-6, 1984 Aug 04.
Artículo en Inglés | MEDLINE | ID: mdl-6146821

RESUMEN

102 patients with endoscopically proven duodenal ulcers were randomly allocated to treatment with ranitidine either 150 mg twice a day or 300 mg every evening for 4 weeks in a prospective double-blind study. The two groups were similar. 48/57 (84%) healed on ranitidine 150 mg twice daily and 43/45 (96%) healed on 300 mg every evening (p = 0.9)--that is, ranitidine 300 mg as a single night time dose is as effective as 150 mg twice daily. The results also indicate the importance of overnight gastric acidity in the pathogenesis of duodenal ulcers.


Asunto(s)
Úlcera Duodenal/tratamiento farmacológico , Ranitidina/administración & dosificación , Adolescente , Adulto , Anciano , Ensayos Clínicos como Asunto , Esquema de Medicación , Úlcera Duodenal/patología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Ranitidina/efectos adversos , Ranitidina/uso terapéutico , Fumar
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda